US FDA study links Asthma drug Montelukast to mental health issues
A study funded by the U.S. government has discovered that a popular asthma drug called Singulair, with the chemical name montelukast, could be linked to severe mental problems in some patients. Researchers uncovered that the medication binds to brain receptors vital for mood regulation, cognition, and impulse control. The research was discussed at a recent